Primis Financial Corp
10 nominees · 4 ballot items.
Election of ten directors; ratification of Crowe LLP as independent auditor; advisory (non-binding) approval of named executive officer compensation; and other business.
Follow how the vote landed and what changed on Primis Financial Corp’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
On the ballot4
- 1
Election of Directors
ManagementBoard: FORElect ten directors to serve until the 2027 annual meeting.
- 2
Ratification of Appointment of Independent Registered Public Accounting Firm
ManagementBoard: FORRatify appointment of Crowe LLP as the Company’s independent registered public accounting firm for fiscal year 2026.
- 3
Advisory Vote on Executive Compensation
ManagementBoard: FORNon-binding advisory vote to approve the compensation of the Company’s named executive officers as disclosed in the proxy statement.
- 4
Other Business
ManagementTo transact such other business as may properly come before the Annual Meeting.
Nominees on the ballot10
Top institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | Patriot Financial Partners GP II, L.P. | 4.9% | 1,217,531 | $16M |
| 2 | ALLIANCEBERNSTEIN L.P. | 4.8% | 1,192,850 | $17M |
| 3 | DIMENSIONAL FUND ADVISORS LP | 4.7% | 1,156,758 | $15M |
| 4 | North Reef Capital Management LP | 4.6% | 1,135,281 | $15M |
| 5 | Curi Capital, LLC | 4.1% | 1,004,288 | $13M |
| 6 | MENDON CAPITAL ADVISORS CORP | 4.0% | 1,002,491 | $13M |
| 7 | VANGUARD CAPITAL MANAGEMENT LLC | 4.0% | 987,787 | $13M |
| 8 | BlackRock, Inc. | 3.5% | 876,251 | $12M |
| 9 | BANC FUNDS CO LLC | 3.5% | 872,961 | $12M |
| 10 | BlackRock, Inc. | 3.3% | 812,589 | $11M |
Other Financial Services sector meetings6
Upcoming shareholder meetings at Primis Financial Corp’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Frequently asked questions
- When is the Primis Financial Corp 2026 annual meeting?
- Primis Financial Corp (FRST) holds its 2026 annual shareholder meeting on Thursday, May 21, 2026.
- What is the record date for the Primis Financial Corp 2026 meeting?
- The record date for the Primis Financial Corp 2026 meeting is Friday, March 27, 2026. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Primis Financial Corp's 2026 meeting?
- The board is presenting 10 director nominees at the Primis Financial Corp 2026 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Primis Financial Corp 2026 meeting?
- Shareholders will vote on 4 proposals at the Primis Financial Corp 2026 meeting, each tagged with who proposed it and the board's recommendation.
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.